awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34246444-3344238D-F251-4C44-B7B1-808FF41FC0C5
Q34246444-3344238D-F251-4C44-B7B1-808FF41FC0C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34246444-3344238D-F251-4C44-B7B1-808FF41FC0C5
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.
P577
Q34246444-3344238D-F251-4C44-B7B1-808FF41FC0C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34246444-3344238D-F251-4C44-B7B1-808FF41FC0C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dfef17cb42bc9a5d5dbf7570544ea906c7128564
P577
2012-01-11T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
f0bc6d5a8951ec279cdf1d03c383f4d3